[1]
Rawshani, A.; Kjölhede, E.A.; Rawshani, A.; Sattar, N.; Eeg-Olofsson, K.; Adiels, M.; Ludvigsson, J.; Lindh, M.; Gisslén, M.; Hagberg, E.; Lappas, G.; Eliasson, B.; Rosengren, A. The Lancet Regional Health - Europe. The Lancet Regional Health - Europe, 2021, 4, 100105.
[2]
Wiersinga, W.J.; Rhodes, A.; Cheng, A.C.; Peacock, S.J.; Prescott, H.C. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): a Review. JAMA, 2020, 324, 782-793.
[3]
Ben, Hu; Guo, H.; Zhou, P.; Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol., 2020, 1-14.
[4]
MD, P.J.Z.; MD, J.T.; MD, C.Y.; MD, P.L.D. The Immunology of COVID-19: Is Immune Modulation an Option for Treatment? The Lancet Rheumatology, 2020, 2, e428-e436.
[5]
Tay, M.Z.; Poh, C.M.; Rénia, L.; MacAry, P.A.; Ng, L.F.P. The Trinity of COVID-19: Immunity, Inflammation and Intervention. Nat. Rev. Immunol., 2020, 1-12.
[6]
Gorbalenya, A.E.; Baker, S.C.; Baric, R.S.; de Groot, R.J.; Drosten, C.; Gulyaeva, A.A.; Haagmans, B.L.; Lauber, C.; Leontovich, A.M.; Neuman, B.W.; Penzar, D.; Perlman, S.; Poon, L.L.M.; Samborskiy, D.V.; Sidorov, I.A.; Sola, I.; Ziebuhr, J. The Species Severe Acute Respiratory Syndrome- Related Coronavirus: Classifying 2019-nCoV and Naming It SARS-CoV-2. Nature Microbiology, 2020, 1-9.
[7]
Gosain, R.; Abdou, Y.; Singh, A.; Rana, N.; Puzanov, I.; Ernstoff, M.S. COVID-19 and Cancer: a Comprehensive Review. 2020, 1-15.
[8]
Derosa, L.; Melenotte, C.; Griscelli, F.; Gachot, B.; Marabelle, A.; Kroemer, G.; Zitvogel, L. The Immuno-Oncological Challenge of COVID-19., Nature Cancer, 2020, 1-19.
[9]
Cao, B.; Wang, Y.; Wen, D.; Liu, W.; Wang, J.; Fan, G.; Ruan, L.; Song, B.; Cai, Y.; Wei, M.; Li, X.; Xia, J.; Chen, N.; Xiang, J.; Yu, T.; Bai, T.; Xie, X.; Zhang, L.; Li, C.; Yuan, Y.; Chen, H.; Li, H.; Huang, H.; Tu, S.; Gong, F.; Liu, Y.; Wei, Y.; Dong, C.; Zhou, F.; Gu, X.; Xu, J.; Liu, Z.; Zhang, Y.; Li, H.; Shang, L.; Wang, K.; Li, K.; Zhou, X.; Dong, X.; Qu, Z.; Lu, S.; Hu, X.; Ruan, S.; Luo, S.; Wu, J.; Peng, L.; Cheng, F.; Pan, L.; Zou, J.; Jia, C.; Wang, J.; Liu, X.; Wang, S.; Wu, X.; Ge, Q.; He, J.; Zhan, H.; Qiu, F.; Guo, L.; Huang, C.; Jaki, T.; Hayden, F.G.; Horby, P.W.; Zhang, D.; Wang, C. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. New England Journal of Medicine, 2020, 382, 1787-1799.
[10]
Nishiga, M.; Wang, D.W.; Han, Y.; Lewis, D.B.; Wu, J.C. COVID-19 and Cardiovascular Disease: From Basic Mechanisms to Clinical Perspectives. Nature Reviews Cardiology, 2020, 1-16.
[11]
Silveira, D.; Prieto-Garcia, J.M.; Boylan, F.; Estrada, O.; Fonseca-Bazzo, Y.M.; Jamal, C.M.; Magalhães, P.O.; Pereira, E.O.; Tomczyk, M.; Heinrich, M. COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy? Front Pharmacol., 2020, 11, 581840-581840.
[12]
Djalante, R.; Lassa, J.; Setiamarga, D.; Sudjatma, A.; Indrawan, M.; Haryanto, B.; Mahfud, C.; Sinapoy, M.S.; Djalante, S.; Rafliana, I.; Gunawan, L.A.; Surtiari, G.A.K.; Warsilah, H. Progress in Disaster Science. Progress in Disaster Science, 2020, 6, 100091.
